Medicine and Dentistry
Oocyte
100%
In Vitro Fertilisation
99%
Pregnancy Rate
54%
Embryo Transfer
49%
In Vitro Maturation
47%
Obstetrics
47%
Embryo Quality
45%
Wart Virus
42%
Ectopic Pregnancy
41%
Methotrexate
40%
Ovarian Hyperstimulation Syndrome
40%
Intracytoplasmic Sperm Injection
39%
Fertility Preservation
38%
Biopsy
38%
Endometrium Tumor
37%
Birth Weight
35%
Hysteroscopy
34%
Fertilization
33%
Disease
32%
Gestational Age
31%
Antral Follicle
31%
Childbirth
28%
Controlled Ovarian Hyperstimulation
27%
Breast Cancer
26%
Vaginal Ultrasonography
26%
Pregnancy
26%
Gonadotropin
25%
Erythrocyte Aggregation
25%
Meta-Analysis
25%
Gonadorelin Agonist
25%
Follicle
25%
Chorionic Gonadotropin
25%
Cesarean Section
23%
Malignant Neoplasm
22%
Cohort Analysis
22%
Symptom
21%
Diethylstilbestrol
21%
C Reactive Protein
21%
Cytotechnology
21%
Cervical Intraepithelial Neoplasia
21%
Assisted Reproductive Technology
21%
Echography
20%
Polycystic Ovary Syndrome
19%
Uterine Cervix Biopsy
18%
Patient Referral
18%
Systematic Review
18%
Progesterone
18%
Ovum
18%
Chlorhexidine
17%
Surgical Infection
17%
Keyphrases
In Vitro Fertilization
71%
Methotrexate
56%
Controlled Ovarian Stimulation
50%
Ectopic Pregnancy
50%
Oocyte number
49%
In Vitro Maturation
48%
High-risk Human Papillomavirus (HR-HPV)
42%
Preimplantation Genetic Diagnosis
40%
Ovarian Response
38%
Live Birth
37%
Methotrexate Treatment
36%
Fertility Preservation
35%
Embryo Quality
34%
Risk Factors
34%
Ovarian Endometriosis
34%
Intracytoplasmic Sperm Injection
34%
Pregnancy Rate
32%
Antral Follicle Count
32%
Ovarian Hyperstimulation Syndrome
31%
CIN2-3
30%
Clinical Pregnancy Rate
29%
Hysteroscopy
28%
Embryo Transfer
28%
Gestational Age
26%
IVF Cycles
26%
Erythrocyte Aggregation
25%
Gonadotropin-releasing Hormone
25%
Meta-analysis
25%
Ovarian Stimulation
25%
Gonadotropins
25%
Treatment Efficacy
25%
Success Rate
24%
High-quality Embryo
24%
Chemotherapy
24%
Laparoscopy
23%
Tertiary Care Hospital
23%
Birth Weight
22%
Fertilization Rate
22%
In Vitro Fertilization-embryo Transfer (IVF-ET)
21%
Implantation Rate
21%
Follicle
21%
Breast Cancer Patients
21%
Polycystic Ovary Syndrome
20%
Cone Biopsy
20%
Adverse Pregnancy Outcomes
20%
Polycystic Ovary
20%
In Vitro Fertilization Cycle
20%
Human Papillomavirus Testing
20%
Adnexal Torsion
20%
Retrospective Cohort Study
18%